Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,656
Closed -$349K 553
2025
Q1
$349K Buy
5,656
+341
+6% +$22.6K 0.04% 358
2024
Q4
$383K Sell
5,315
-343
-6% -$26.8K 0.05% 313
2024
Q3
$461K Buy
5,658
+76
+1% +$6.08K 0.06% 279
2024
Q2
$414K Buy
5,582
+30
+0.5% +$2.25K 0.05% 291
2024
Q1
$433K Sell
5,552
-187
-3% -$13.9K 0.06% 303
2023
Q4
$410K Buy
5,739
+217
+4% +$15.1K 0.06% 296
2023
Q3
$383K Sell
5,522
-522
-9% -$39.4K 0.06% 284
2023
Q2
$489K Sell
6,044
-1,992
-25% -$163K 0.07% 250
2023
Q1
$648K Sell
8,036
-29
-0.4% -$2.33K 0.11% 200
2022
Q4
$603K Buy
8,065
+4,216
+110% +$300K 0.11% 207
2022
Q3
$248K Sell
3,849
-542
-12% -$37.5K 0.05% 374
2022
Q2
$304K Buy
+4,391
New +$326K 0.06% 319

Other funds holding HOLX

Wealth Alliance's HOLX Position: Q2 2025 in Review

Wealth Alliance sold out of Hologic (HOLX) in Q2 2025, closing a stake of 5,656 shares — an estimated $349K sold.

Wealth Alliance first reported a position in HOLX in Q2 2022 and held it in 12 quarters. The position peaked at $648K in Q1 2023. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Wealth Alliance reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Wealth Alliance sold 5,656 Hologic shares in Q2 2025, an estimated $349K.
  • Wealth Alliance first reported a position in Hologic in Q2 2022 and held it in 12 quarters.
  • Wealth Alliance's Hologic position peaked at $648K in Q1 2023.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Wealth Alliance's 13F filing for Q2 2025, filed 8 Aug 2025.